SAHAREK JOHN P.
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to SAHAREK JOHN P.. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| HROW | CEO & President, ImprimisRx | Option Exercise | 277,200 | — | — | Apr 7, 2025 |
| HROW | CEO of ImprimisRx | Tax Withholding | 45,140 | $41.37 | $1,867,442 | Sep 11, 2024 |
| HROW | CEO of ImprimisRx | Option Exercise | 5,000 | $8.75 | $43,750 | Mar 1, 2024 |
| HROW | CEO of ImprimisRx | Option Exercise | 30,000 | $10.67 | $320,100 | Feb 20, 2024 |
| HROW | Chief Commercial Officer | Tax Withholding | 9,778 | $12.83 | $125,452 | Nov 10, 2023 |
| HROW | Chief Commercial Officer | Tax Withholding | 109,080 | $18.23 | $1,988,528 | Jul 18, 2023 |
| HROW | President, ImprimisRx | Tax Withholding | 25,923 | $7.87 | $204,014 | Feb 19, 2022 |
| HROW | Chief Commercial Officer | Option Exercise | 30,000 | $1.83 | $54,900 | Feb 1, 2018 |
| HROW | Chief Commercial Officer | Award / Grant | 30,000 | — | — | Feb 1, 2015 |